Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Dermatologic 3Other hematologic neoplasm 1

Conditions

Hodgkin Disease 33Lymphoma 17Lymphoma, Large-Cell, Anaplastic 15Hematologic Diseases 13Lymphoma, Non-Hodgkin 10Recurrence 9Lymphoma, T-Cell 7Lymphoma, T-Cell, Peripheral 6Lymphoma, Large B-Cell, Diffuse 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, B-Cell 4Neoplasms 3Mycosis Fungoides 3Lymphoma, T-Cell, Cutaneous 3Lymphatic Diseases 3Leukemia 3Immunoblastic Lymphadenopathy 3Sezary Syndrome 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms, Germ Cell and Embryonal 2Neoplasms by Histologic Type 2Lymphoproliferative Disorders 2Lymphoma, Extranodal NK-T-Cell 2Leukemia, Myeloid, Acute 2Immunoproliferative Disorders 2Immune System Diseases 2Enteropathy-Associated T-Cell Lymphoma 2Waldenstrom Macroglobulinemia 1Testicular Neoplasms 1Nonseminomatous germ cell tumor 1

Interventions

fludarabine phosphate 19Whole-Body Irradiation 15Peripheral Blood Stem Cell Transplantation 15Mycophenolic Acid 15Tacrolimus 12Cyclophosphamide 11Cyclosporine 10Busulfan 10Antilymphocyte Serum 10Methotrexate 8Rituximab 7Etoposide 6Melphalan 5Flow Cytometry 5pembrolizumab 4Radiotherapy 4Panobinostat 4Lenalidomide 4Filgrastim 4Everolimus 4Dexamethasone 4Calcium Dobesilate 4Bexarotene 4thymoglobulin 3romidepsin 3hypericin 3fludarabine 3Therapeutics 3Sirolimus 3In Situ Hybridization, Fluorescence 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Mycosis Fungoides × Brentuximab Vedotin × Clear all
NCT01805037 2021-09-01

Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas

Northwestern University

Phase 1/2 Terminated
20 enrolled 17 charts
DermatologicLymphoidOther hematologic neoplasm

Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Mycosis Fungoides, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Epstein-Barr Virus Infections, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Intraocular Lymphoma

NCT01578499 2021-01-05

ALCANZA

Takeda

Phase 3 Completed
131 enrolled 24 charts
DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous, Lymphoma, Primary Cutaneous Anaplastic Large Cell

NCT01396070 2017-04-05

Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level

Stanford University

Phase 2 Completed
36 enrolled 13 charts
DermatologicLymphoid

Lymphoma, Non-Hodgkin, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡